Entity coverage

Jaguar Health, Inc.

JAGX · 5 events mapped

Market Ontology has mapped 5 distinct macro, policy, and market events to JAGX. Each entry below traces the causal channel from the driver to the assumption it moved.

Recent event impacts

Full ledger →
  • 2026-06-25EventDirect disclosure of a material definitive agreement, which could be an acquisition, divestiture, significant partnership, or financing event.
  • 2026-06-25EventDilution from conversion of preferred stock into common stock, increasing the share count.
  • 2026-06-22EventRegulatory disclosure of potentially material non-public information. The specific content of the 8-K is unknown without further detail, but Regulation FD filings often precede or accompany significant corporate events.
  • 2026-06-22EventUncertainty regarding the outcome of strategic review; potential for no deal or a dilutive transaction.
  • 2026-06-22EventPotential acquisition premium or partnership deal for its rare disease drug candidate, crofelemer.

Continuous coverage for JAGX with alerts, structural playbooks, and options routing lives in the platform. Start a trial →